JCO global oncologyAdultAgedFemaleHumansMale
Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health System.
Gabriel Lenz, Rafael Alvim Pereira, Wallace Klein Schwengber, Milena Tumelero, Nicolas Peruzzo, Leonardo Stone Lago, Gilberto Lopes
Published: 202510.1200/GO-25-00302
Abstract
PURPOSE: Lung cancer remains a leading cause of cancer mortality in Brazil, with non-small cell lung cancer (NSCLC) accounting for 85% of cases, with 1.6% carrying epidermal growth factor receptor (EGFR) exon 20 mutations. In the phase I CHRYSALIS tr…
Preview only. Read the full abstract at the source